PreviousNextExpandCollapseSearch

Web Page-Physician

Physician Study Phase Disease Study Number Summary Status Total
Hide details for Abenaa M. BrewsterAbenaa M. Brewster
2
Hide details for N/AN/A
2
  Breast  2013-0752   Treatment Decisions and Breast Cancer: Psychosocial Outcomes  Open
  Breast  ID01-001   Epidemiologic and Genetic Determinants of Breast Cancer Survival  Open
Hide details for Abigail S. CaudleAbigail S. Caudle
2
Hide details for Phase IIIPhase III
1
  Breast  ALLIANCE-A011106   ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: A Phase III Study  Open
Hide details for N/AN/A
1
  Breast  2013-0877   Correlating Fine Needle Aspiration to surgical excision to assess for eradication of nodal metastases after chemotherapy in breast cancer  Open
Hide details for Adi DiabAdi Diab
9
Hide details for Phase IPhase I
4
  Gastrointestinal  2014-0996   A PHASE 1, OPEN-LABEL, DOSE ESCALATION STUDY OF PF-04518600 IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA (HCC), MELANOMA, CLEAR CELL RENAL CELL CARCINOMA (RCC) OR SQUAMOUS CELL HEAD AND NECK CANCER (SCCHN)  Open
  Genitourinary  2014-0996   A PHASE 1, OPEN-LABEL, DOSE ESCALATION STUDY OF PF-04518600 IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA (HCC), MELANOMA, CLEAR CELL RENAL CELL CARCINOMA (RCC) OR SQUAMOUS CELL HEAD AND NECK CANCER (SCCHN)  Open
  Head And Neck  2014-0996   A PHASE 1, OPEN-LABEL, DOSE ESCALATION STUDY OF PF-04518600 IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA (HCC), MELANOMA, CLEAR CELL RENAL CELL CARCINOMA (RCC) OR SQUAMOUS CELL HEAD AND NECK CANCER (SCCHN)  Open
  Melanoma  2014-0996   A PHASE 1, OPEN-LABEL, DOSE ESCALATION STUDY OF PF-04518600 IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA (HCC), MELANOMA, CLEAR CELL RENAL CELL CARCINOMA (RCC) OR SQUAMOUS CELL HEAD AND NECK CANCER (SCCHN)  Open
Hide details for Phase I/Phase IIPhase I/Phase II
4
  Lung  2015-0573   A PHASE 1/2, OPEN-LABEL, MULTICENTER, DOSE ESCALATION AND DOSE EXPANSION STUDY OF NKTR-214 IN SUBJECTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMOR MALIGNANCIES  Open
  Melanoma  2015-0530   A Phase I/II Study to Assess the Safety and Efficacy of Intratumoral IMO-2125 in Combination with Ipilimumab in Patients with Metastatic Melanoma  Open
  Melanoma  2015-0573   A PHASE 1/2, OPEN-LABEL, MULTICENTER, DOSE ESCALATION AND DOSE EXPANSION STUDY OF NKTR-214 IN SUBJECTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMOR MALIGNANCIES  Open
  Solid Tumors  2015-0573   A PHASE 1/2, OPEN-LABEL, MULTICENTER, DOSE ESCALATION AND DOSE EXPANSION STUDY OF NKTR-214 IN SUBJECTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMOR MALIGNANCIES  Open
Hide details for Phase IIPhase II
1
  Melanoma  2011-1157   Phase II Study of Abraxane Plus Ipilimumab in Patients with Metastatic Melanoma  Open
Hide details for Ahmed KasebAhmed Kaseb
2
Hide details for Phase IPhase I
1
  Liver  2015-0221   A Phase I Dose Escalation Study to Investigate the Safety, Immunoregulatory Activity, Pharmacokinetics, and Preliminary Antitumor Activity of Anti-Programmed-Death-1 (PD-1) Antibody (BMS-936558) in Advanced Hepatocellular Carcinoma in Subjects with or without Chronic Viral Hepatitis (CA209-040)  Open
Hide details for Phase IIPhase II
1
  Liver  2012-0870   A Phase II study of Sorafenib and Yttrium-90 Glass Microspheres for Advanced Hepatocellular Carcinoma, BCLC Stage C   Open
Hide details for Ahsan AzharAhsan Azhar
2
Hide details for N/AN/A
2
  Advanced Cancers  2014-0199   Response to Opioids for Breakthrough Pain in Advanced Cancer Patients with Adequately Controlled Background Pain  Open
PreviousNextExpandCollapseSearch